首页 | 官方网站   微博 | 高级检索  
     

siMDR1重组慢病毒载体的构建及其对A549和A549/DDP细胞的影响
引用本文:黄建峰,沈振亚,许林,余云生,叶文学,黄浩岳.siMDR1重组慢病毒载体的构建及其对A549和A549/DDP细胞的影响[J].中国癌症杂志,2009,19(7):497-502.
作者姓名:黄建峰  沈振亚  许林  余云生  叶文学  黄浩岳
作者单位:1. 苏州大学附属第一医院胸心外科,江苏,苏州,215006
2. 江苏省肿瘤医院胸外科,江苏,南京,210000
摘    要:背景与目的:肿瘤细胞的多药耐药性(multidrug resistance,MDR)是导致化疗失败的最主要原因,也是癌症术后复发及转移的主要原因.本研究旨在探讨MDR1基因RNA干扰(RNA interference,RNAi)重组慢病毒对人肺腺癌A549细胞和对顺铂耐药的A549/DDP细胞的MDR1基因的抑制作用.方法:设计获得针对MDR1的短发卡状RNA(small hair pin RNA,shRNA)的寡核苷酸序列,退火后插入线性化的pSUPER载体(H1启动子下游).把构建获得的载体转染A549细胞,RT-PCR法检测其对MDR1的干扰作用,筛选确定MDR1基因RNAi有效靶序列;合成靶序列的01igo DNA,与含启动子和绿色荧光蛋白(green fluorescent protein,GFP)的PTM载体连接产生PTM-siMDR1慢病毒载体;用重组慢病毒体外感染A549和A549/DDP细胞.结果:成功构建可以表达针对MDR1的发卡状RNAi,能有效的下调MDR1的表达.成功构建获得针对MDR1基因的慢病毒载体PTM-siMDR1,包装慢病毒,浓缩病毒悬液的滴度为0.5×109TU/mL.感染PTM-siMDRI的A549/DDP细胞对顺铂的敏感性明显提高,逆转倍数达3.81倍.结论:siiDR1重组慢病毒载体感染A549/DDP细胞,能明显改善其对顺铂的耐药性.

关 键 词:RNA干扰  多药耐药基因  A549/DDP细胞

Construction of lentiviral vector of RNA interference and its effect on A549 and A549/DDP cells
HUANG Jian-feng,SHEN Zhen-ya,XU Lin,YU Yun-sheng,YE Wen-xue,HUANG Hao-yue.Construction of lentiviral vector of RNA interference and its effect on A549 and A549/DDP cells[J].China Oncology,2009,19(7):497-502.
Authors:HUANG Jian-feng  SHEN Zhen-ya  XU Lin  YU Yun-sheng  YE Wen-xue  HUANG Hao-yue
Abstract:Background and purpose: Multidrug resistance (MDR) of tumor cell is the main reason for clinical chemotherapy failure as well as cancer recurrence and metastasis. This study was to construct a lentiveral vector of RNA interference of MDR1 gene and observe its inhibitive role on the expression of MDR1 in A549 and A549/DDP cells. Methods: Oligos of base pairs for hairpin RNA targeting MDR1 were chemically synthesized. Via annealing and inserting them into the down-stream of H1 promoter of linearized pSUPER, we obtained the siRNA constructs for MDR1, which were afterwards transfected into A549, a human lung cancer cell line expressing high level MDR1, the impact of constructs was observed on the expression and interference efficiency of siRNA against MDR1. The effective sequence of siRNA targeting MDR1 gene was confirmed. Both sense and antisence oligo DNA of the targeting sequence was designed, synthesized and cloned into the PTM vector, containing a promoter and a green fluorescent protein (GFP). The resulting lentiviral vector containing MDR1 siRNA was named PTM-siMDR1 and then transfected into A549 and A549/DDP cells after being confirmed by PCR and sequencing. Results: Restriction digestion and DNA sequencing showed that the siRNA constructs for MDR1 were successfully produced and the expressed siRNA could effectively down-regnlate the expression of MDRI. PCR demonstrated that the lentivirus RNAi vector of MDR1 producing PTM-siMDR1 was constructed successfully. The chemosensitivity of A549/DDP cells to cisplatin were enhanced obviously after trartsfection. Conclusion: The lentivirus RNAi vector of MDR1 can significantly revise the resistance ofA549/ DDP cells with eisplatin after infection.
Keywords:siRNA  siRNA  RNA interference  multidrug resistance gene  A549/DDP cells
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号